Figure 2
Outcome of CBF-AML patients after first relapse (N = 145). DFS and OS according to (A) CBFA vs CBFB status, (B) CR1 duration (<1 vs ≥1 year), and (C) administration of GO in salvage therapy.
Outcome of CBF-AML patients after first relapse (N = 145). DFS and OS according to (A) CBFA vs CBFB status, (B) CR1 duration (<1 vs ≥1 year), and (C) administration of GO in salvage therapy.
